HCM
GSK icon

Hamlin Capital Management’s GSK GSK Stock Holding History

Hamlin Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,418,398
Closed -$72M – 41
2017
Q3 		$72M Buy
1,418,398
+6,306
+0.4% +$320K 2.92% 19
2017
Q2 		$76.1M Buy
1,412,092
+2,402
+0.2% +$128K 3.18% 18
2017
Q1 		$74.3M Buy
1,409,690
+232,168
+20% +$11.8M 3.14% 16
2016
Q4 		$56.7M Sell
1,177,522
-9,942
-0.8% -$491K 2.54% 23
2016
Q3 		$64M Buy
1,187,464
+16,946
+1% +$929K 2.96% 11
2016
Q2 		$63.4M Buy
1,170,518
+7,293
+0.6% +$384K 3.07% 15
2016
Q1 		$59M Sell
1,163,225
-16,683
-1% -$831K 2.98% 18
2015
Q4 		$59.5M Buy
1,179,908
+87,200
+8% +$4.44M 3.22% 15
2015
Q3 		$52.5M Sell
1,092,708
-22,924
-2% -$1.19M 2.9% 17
2015
Q2 		$58.1M Buy
1,115,632
+11,187
+1% +$630K 2.93% 13
2015
Q1 		$63.7M Buy
1,104,445
+95,500
+9% +$5.47M 3.36% 7
2014
Q4 		$53.9M Buy
1,008,945
+34,649
+4% +$1.94M 3.01% 15
2014
Q3 		$56M Buy
974,296
+198,592
+26% +$12.2M 3.36% 5
2014
Q2 		$51.9M Buy
775,704
+71,032
+10% +$4.81M 2.91% 13
2014
Q1 		$47.1M Buy
704,672
+33,928
+5% +$2.29M 3.02% 15
2013
Q4 		$44.8M Buy
670,744
+31,684
+5% +$2.05M 3.05% 11
2013
Q3 		$40.1M Buy
639,060
+27,144
+4% +$1.75M 3% 19
2013
Q2 		$38.2M Buy
+611,916
New +$38.8M 3.12% 13

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hamlin Capital Management's GSK Position: Q4 2017 in Review

Hamlin Capital Management sold out of GSK (GSK) in Q4 2017, closing a stake of 1,418,398 shares — an estimated $72M sold.

Hamlin Capital Management first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $76.1M in Q2 2017. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Hamlin Capital Management reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Hamlin Capital Management sold 1,418,398 GSK shares in Q4 2017, an estimated $72M.
  • Hamlin Capital Management first reported a position in GSK in Q2 2013 and held it in 18 quarters.
  • Hamlin Capital Management's GSK position peaked at $76.1M in Q2 2017.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Hamlin Capital Management's 13F filing for Q4 2017, filed 31 Jan 2018.